GENE EXPRESSION SIGNATURES ASSOCIATED WITH RESPONSE TO IMATINIB MESYLATE IN GASTROINTESTINAL STROMAL TUMORS AND USE THEREOF FOR PREDICTING PATIENT RESPONSE TO THERAPY AND IDENTIFICATION OF AGENTS WHICH HAVE EFFICACY FOR THE TREATMENT OF CANCER
Andrew K. Godwin,Burton Eisenberg,Yuliya Skorobogatko,Lori Rink,Andrew Kossenkov,Michael F. Ochs
申请号:
US13265686
公开号:
US20130058992A1
申请日:
2010.04.21
申请国别(地区):
US
年份:
2013
代理人:
摘要:
Compositions and methods are disclosed for identifying agents useful for the treatment of malignancy, particularly GISTs which are resistant to imatinib mesylate (IM). In a preferred embodiment, agents which sensitize cancer cells to IM are provided.